Results of intensive chemotherapy in children with juvenile chronic myelomonocytic leukemia: a pilot study.

@article{Heredia1998ResultsOI,
  title={Results of intensive chemotherapy in children with juvenile chronic myelomonocytic leukemia: a pilot study.},
  author={Cristina D{\'i}az de Heredia and Juan J. Ortega and Miquel Coll and Pilar Bastida and Teresa Oliv{\'e}},
  journal={Medical and pediatric oncology},
  year={1998},
  volume={31 6},
  pages={516-20}
}
BACKGROUND The use of chemotherapy in juvenile chronic myelomonocytic leukemia (J-CMML) has not generally been successful. Our previous experience in 11 patients demonstrated that chemotherapy with low doses of daunorubicin or cytarabine resulted in a 90% fatal outcome and a median survival rate of only 7 months. PROCEDURE AND RESULTS Between 1985 and 1997, six children (five boys and one girl) aged 3-67 months (median age: 20.5) were diagnosed with J-CMML and underwent intensive combination… CONTINUE READING